{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:45:28Z","timestamp":1792266328706,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06332-9","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:42:31Z","timestamp":1792215751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in biventricular myocardial function after six months of ixekizumab therapy in patients with psoriatic arthritis: a prospective speckle-tracking echocardiographic study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-8639","authenticated-orcid":false,"given":"Nikolaos","family":"Kougkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-4888","authenticated-orcid":false,"given":"Dimitrios","family":"Deligeorgakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8340-9423","authenticated-orcid":false,"given":"George","family":"Koulaouzidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinelopi","family":"Giannakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4741-1096","authenticated-orcid":false,"given":"Nikolaos","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Zarifis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3131-4973","authenticated-orcid":false,"given":"Evdokia","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-1642","authenticated-orcid":false,"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3802-6877","authenticated-orcid":false,"given":"Adam","family":"Tsaousidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"issue":"2","key":"6332_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/eurjrheum.2025.24078","volume":"12","author":"D Deligeorgakis","year":"2025","unstructured":"Deligeorgakis D, Skouvaklidou E, Skepastianos V, Tsafis K, Kougkas N (2025) Uveitis in Psoriatic Arthritis: A Comprehensive Review. Eur J Rheumatol 12(2):1\u20137. https:\/\/doi.org\/10.5152\/eurjrheum.2025.24078","journal-title":"Eur J Rheumatol"},{"issue":"4","key":"6332_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40744-026-00860-3","volume":"13","author":"K Tsafis","year":"2026","unstructured":"Tsafis K, Skepastianos V, Skouvaklidou E, Deligeorgakis D, Boutel M, Kontonikola A, Papazoglou N, Fragoulis GE, Kougkas N (2026) Cutaneous Manifestations in Psoriatic Arthritis: Phenotypes, Clinical Burden, and Therapeutic Implications. Rheumatol therapy 13(4):931\u2013949. https:\/\/doi.org\/10.1007\/s40744-026-00860-3","journal-title":"Rheumatol therapy"},{"issue":"4","key":"6332_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.31138\/mjr.300125.pac","volume":"36","author":"BS Kahlow","year":"2025","unstructured":"Kahlow BS, Beckhauser AP, Skare TL, Nisihara R (2025) Analysis of Cardiovascular Risk Factors in Patients with Psoriasis: A Cross-Sectional Study. Mediterranean J Rheumatol 36(4):609\u2013615. https:\/\/doi.org\/10.31138\/mjr.300125.pac","journal-title":"Mediterranean J Rheumatol"},{"issue":"21","key":"6332_CR4","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","volume":"100","author":"K Kalam","year":"2014","unstructured":"Kalam K, Otahal P, Marwick TH (2014) Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 100(21):1673\u20131680. https:\/\/doi.org\/10.1136\/heartjnl-2014-305538","journal-title":"Heart"},{"issue":"3","key":"6332_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.55563\/clinexprheumatol\/al5kv6","volume":"44","author":"N Kougkas","year":"2026","unstructured":"Kougkas N, Skouvaklidou E, Tsafis K, Deligeorgakis D, Skepastianos V, Adamichou C, Papadimitriou E, Mpitouli A, Boutel M, Dimitriadis F, Spagos G, Zarifis I, Dimitroulas T, Tsaousidis A (2026) Cardiac strain in patients on Janus Kinase inhibitors for rheumatic diseases: a 1-year echocardiographic study. Clin Exp Rheumatol 44(3):527\u2013533. https:\/\/doi.org\/10.55563\/clinexprheumatol\/al5kv6","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"6332_CR6","doi-asserted-by":"publisher","first-page":"7051","DOI":"10.1038\/s41598-026-37835-x","volume":"16","author":"S Gentileschi","year":"2026","unstructured":"Gentileschi S, Terribili R, Gaggiano C, Fiorentini E, Cometi L, Cigolini C, Perrotta FM, Scriffignano S, Di Cato L, Panaccione A, Niccoli L, Cantini F, Benucci M, Li Gobbi F, Delle Sedie A, Vitale A, Lubrano E, Frediani B, Guiducci S (2026) Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study. Sci Rep 16(1):7051. https:\/\/doi.org\/10.1038\/s41598-026-37835-x","journal-title":"Sci Rep"},{"issue":"1","key":"6332_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s13555-024-01323-9","volume":"15","author":"M Lebwohl","year":"2025","unstructured":"Lebwohl M, Deodhar A, Schwartzman S, Salvarani C, Feely McDonald M, Bello N, Grace EL, Inman E, Kronbergs A, Ngantcha M, Rahman P, Papp KA, Merola JF, Gottlieb AB, Blauvelt A (2025) Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events. Dermatology therapy 15(1):161\u2013188. https:\/\/doi.org\/10.1007\/s13555-024-01323-9","journal-title":"Dermatology therapy"},{"issue":"8","key":"6332_CR8","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673. https:\/\/doi.org\/10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"issue":"5","key":"6332_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","volume":"75","author":"MM Schoels","year":"2016","unstructured":"Schoels MM, Aletaha D, Alasti F, Smolen JS (2016) Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis 75(5):811\u2013818. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207507","journal-title":"Ann Rheum Dis"},{"key":"6332_CR10","doi-asserted-by":"publisher","unstructured":"McEvoy JW, McCarthy CP (2024) 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. 45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178","DOI":"10.1093\/eurheartj\/ehae178"},{"issue":"4","key":"6332_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"6332_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J, Helliwell PS (2010) Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69(1):48\u201353. https:\/\/doi.org\/10.1136\/ard.2008.102053","journal-title":"Ann Rheum Dis"},{"key":"6332_CR13","doi-asserted-by":"publisher","unstructured":"Kaleta K, Krupa J (2024) Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis. 44(9):1587\u20131606. https:\/\/doi.org\/10.1007\/s00296-024-05556-x","DOI":"10.1007\/s00296-024-05556-x"},{"issue":"4","key":"6332_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3899\/jrheum.130589","volume":"41","author":"Q Shang","year":"2014","unstructured":"Shang Q, Tam LS, Sanderson JE, Lee AP, Li EK, Yu CM (2014) Impaired left ventricular apical rotation is associated with disease activity of psoriatic arthritis. J Rhuematol 41(4):706\u2013713. https:\/\/doi.org\/10.3899\/jrheum.130589","journal-title":"J Rhuematol"},{"key":"6332_CR15","doi-asserted-by":"publisher","unstructured":"Tsigaridas N, Mantzoukis S, Mantzoukis S, Toli E, Toli E, Tsimos K, Tsimos K, Varsamis N, Varsamis N, Gerasimou M, Gerasimou M, Gianniki M, Gianniki M, Patsouras D, Patsouras D, Tsifetaki N, Tsifetaki N (2020) P1767 Abnormal longitudinal peak systolic strain in asymptomatic patients with psoriatic arthritis. Eur Heart J - Cardiovasc Imaging 21. https:\/\/doi.org\/10.1093\/ehjci\/jez319.1125. (Supplement_1)","DOI":"10.1093\/ehjci\/jez319.1125"},{"issue":"2","key":"6332_CR16","first-page":"131","volume":"41","author":"B Yilmazer","year":"2016","unstructured":"Yilmazer B, Sahin T, Cefle A (2016) Impaired myocardial deformation in psoriatic arthritis patients assessment by speckle tracking echocardiography. Acta reumatologica portuguesa 41(2):131\u2013137","journal-title":"Acta reumatologica portuguesa"},{"key":"6332_CR17","doi-asserted-by":"publisher","first-page":"107879","DOI":"10.1016\/j.phrs.2025.107879","volume":"219","author":"L Ma","year":"2025","unstructured":"Ma L, Yang W, Gao W, Liu X, Dong M, An G, Meng X (2025) IL-17 as a therapeutic target in cardiovascular diseases: Mechanistic insights and translational opportunities. Pharmacol Res 219:107879. https:\/\/doi.org\/10.1016\/j.phrs.2025.107879","journal-title":"Pharmacol Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06332-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06332-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06332-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:03:18Z","timestamp":1792263798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06332-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":17,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["6332"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06332-9","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"28 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Committee of General Hospital of \u2018G. Papanikolaou\u2019, Thessaloniki, Greece (approval\/reference number 665, approval date: 27 May 2025). All participants provided written informed consent prior to enrollment. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, the authors used artificial intelligence tools to assist with language editing and manuscript organization (Open AI ChatGPT, accessed June-July 2026). All scientific content, study design, data analysis, interpretation of results, and final decisions regarding the manuscript were performed and verified by the authors. The authors take full responsibility for the content of this publication.","order":4,"name":"Ethics","label":"Generative AI disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"289"}}